The Signal Amplification by Reversible Exchange (SABRE) has been awarded 3.6 million euros ($4.7 million U.S.) from the Wellcome Trust to develop an MRI technique to view molecular activities behind diseases, such as Alzheimer's Disease.
The new grant brings the total support for SABRE from the Wellcome Trust, the Wolfson Foundation, Bruker Biospin, the University of York, and the Engineering and Physical Sciences Research Council (EPSRC) to more than 12.5 million euros ($16.3 million U.S.) in the last three years.
A new Centre for Hyperpolarisation in Magnetic Resonance (CHyM) is being built at York to house the project. The building, which is nearing completion at York Science Park, includes a chemical laboratory, four high-field nuclear magnetic resonance systems, and space for 30 research scientists.
